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Abstract 
 
In 1998, Dr. Andrew Wakefield began promoting the idea that the MMR vaccine could 
be linked to autism. The media soon picked up on Wakefield’s idea, propagating a myth about 
vaccines and autism with celebrity assistance and the support of certain government officials. As 
a result, vaccination rates dropped, outbreaks of diseases normally prevented by vaccination 
occurred, and segments of the population developed long-term concerns about vaccine safety. 
All this happened in spite of multiple studies and reports from researchers and prominent health 
agencies denying a causal connection between autism and vaccines as well as an in-depth 
investigation that ultimately found Wakefield’s work to be the product of severe ethical 
violations. That the myth has persisted in the face of such damning evidence to the contrary 
demonstrates the power of the Internet and its wealth of (mis)information, a development with 
which public health agencies and the medical community must come to terms if they are to 
combat the vaccine-autism myth effectively. The medical community must also begin to engage 
in more dialogue with parents so that doctors can demonstrate to parents why their expertise 
should be trusted over the myriad of information available online. By rebuilding parental trust in 
the medical profession as opposed to the Internet, the vaccine-autism myth may finally be 
rejected so that children will be protected from disease and attention can turn to the pressing 
issue of what actually causes autism. This result would be the most beneficial outcome for 
children, a goal that all parties to the controversy can support. 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Introduction: A Brief History of Vaccinations 
Throughout history, diseases have wreaked havoc on the human population. For example, 
smallpox, a once-dreaded virus, has been traced back to at least the second century AD.
1 In the 
1500s, when Europeans and their illnesses first began appearing on the shores of the New World, 
smallpox devastated indigenous populations, killing one-third of the natives in a remarkably 
short period of time.
2 And although Europeans had a higher level of immunity to smallpox due to 
prolonged exposure, they were not entirely protected: in the 18th century, approximately 400,000 
Europeans died annually from the virus.
3 While terrifying, smallpox was not the only disease 
capable of such deadly outcomes at the time.
4 
  Given the devastation caused by smallpox and many other contagious diseases, their 
virtual disappearance from much of the industrialized world is a cause for celebration. And the 
guest of honor at such a celebration would be the vaccine. Indeed, the Centers for Disease 
Control and Prevention (“CDC”) has compiled a list of the greatest public health achievements 
of the 20th century, with vaccinations taking first place on the list.
5 The first vaccine was 
developed in the late 18th century by Edward Jenner, an English country doctor. He observed 
that milkmaids who were infected with cowpox were subsequently immune from smallpox. 
Based on this observation, Jenner inoculated a boy with pus from a cowpox lesion and then 
repeatedly exposed the child to smallpox. When this and other similar experiments demonstrated 
                                                             
1 John M. Eyler, Smallpox in History: The Birth, Death, and Impact of a Dread Disease, 142 J. OF LABORATORY & 
CLINICAL MED. 216, 216 (2003). 
2 WILLIAM H. MCNEILL, PLAGUES AND PEOPLES 217 (1998). 
3 Eyler, supra note 1, at 216. 
4 Measles, typhus, influenza, diphtheria, and mumps are examples of other potentially deadly diseases in existence 
by the 1500s. MCNEILL, supra note 2, at 217-18. Even into the late 19th century, some of these maladies were 
responsible for killing one in five children in the United States before he or she reached the age of five. Alexandra 
Minna Stern & Howard Markel, The History of Vaccines and Immunization: Familiar Patterns, New Challenges, 24 
HEALTH AFF. 611, 611 (2005). 
5 CDC, Ten Great Public Health Achievements -- United States, 1900-1999, 48 MORBIDITY AND MORTALITY WKLY 
REP. 241 (1999), available at http://www.cdc.gov/mmwr/preview/mmwrhtml/00056796.htm.  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that the inoculated subjects did not develop smallpox, Jenner published his findings in a book in 
1798 entitled Inquiry into the Causes and Effects of the Variolae Vaccine.
6 Although some 
immediately praised Jenner’s work and saw it as the herald of the end of smallpox,
7 actual 
eradication of the disease did not occur until almost two centuries later. 
European countries first began promoting smallpox vaccination in the early 19th century, 
moving to increasingly forceful methods in order to obtain compliance from citizens.
8 For 
example, England passed several Vaccinations Acts in the mid-19th century. The first Act, 
passed in 1840, provided free vaccination to the poor. By 1853, compulsory vaccination of 
infants under three months of age had been established in the country.
9 Along with mandatory 
vaccination, England undertook to improve the infrastructure supporting vaccination, by issuing 
new rules aimed at improving the quality of the vaccine itself as well as the skill of those who 
conducted vaccinations.
10 Following these improvements, England passed another Vaccination 
Act in 1867, making vaccinations mandatory for all children under fourteen years of age. Parents 
who did not get their children vaccinated could be fined repeatedly until they complied with the 
law.
11 
The United States was similarly interested in Jenner’s discovery. In 1800, Dr. Benjamin 
Waterhouse of Harvard Medical School conducted his own experiments and verified Jenner’s 
findings.
12 Physicians soon began offering vaccinations. However, smallpox vaccination ran into 
several difficulties in the United States, the most significant one having to do with obtaining a 
                                                             
6 Stern & Markel, supra note 4, at 612. 
7 Eyler, supra note 1, at 218 (quoting a letter from Thomas Jefferson to Jenner praising the latter for his discovery). 
8 Id. 
9 Dorothy Porter & Roy Porter, The Politics of Prevention: Anti-Vaccinationism and Public Health in Nineteenth-
Century England, 32 MED. HIST. 231, 231-33 (1988). 
10 See id. at 233. 
11 Id. 
12 Rohit K. Singla, Missed Opportunities: The Vaccine Act of 1813, in Chapter I(A) of the Electronic Book 19 
(1998).  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pure source of the vaccine.
13 At the time, there was no known method to produce the vaccine 
artificially. Instead, physicians relied on arm-to-arm transmissions, harvesting live cowpox virus 
from the infected pustule of a vaccinated person and using it to vaccinate other individuals.
14 
One of the major problems with carrying out vaccinations in this manner was that other diseases 
could also be spread from one person to the next.
15 In response, Congress enacted the Vaccine 
Act of 1813 to secure a genuine national source for the smallpox vaccine.
16 While the Act was 
repealed in 1822, the repeal may have had more to do with politics rather than animus towards 
vaccination.
17 
England’s Vaccination Acts experienced opposition as well. Not everyone believed in the 
efficacy of vaccination; even members of the medical community were against the procedure.
18 
Vaccination was also objected to for religious reasons because it was seen as an improper 
interference with Divine Providence.
19 Once vaccinations became compulsory, a National Anti-
Compulsory Vaccination League was formed to seek repeal of the vaccination acts.
20 The 
League was not entirely successful, but managed to obtain a conscience clause in the 
Vaccination Act of 1989, which excused parents who genuinely believed vaccines to be 
ineffective and who did not want infectious materials to be introduced into their children from 
being fined for disobeying the law.
21 A similar conscientious objection provision has survived 
                                                             
13 Id. at 24. 
14 Id. at 27. 
15 Id. at 28 (“The accidental transmission of syphilis was particularly common”); Porter & Porter, supra note 9, at 
233-34 (two accounts of syphilis being transmitted through arm-to-arm vaccination in England gave rise to concerns 
about other diseases being spread in the same way). 
16 Singla, supra note 12, at 40. 
17 Singla posits that the repeal of the Act was mainly “a politically expedient response” to a mistake in which the 
National Vaccine Agent responsible for providing pure vaccines accidentally sent a doctor in North Carolina 
samples of smallpox to use in vaccinating people, resulting in a smallpox outbreak that killed several people. Id. at 
66-67. 
18 Porter & Porter, supra note 9, at 236-37. 
19 Id. 
20 Eyler, supra note 1, at 219. 
21 Porter & Porter, supra note 9, at 234, 251.   
4 
 
into the modern day and is being used by parents in the wake of the vaccine-autism controversy 
to excuse their children from receiving certain vaccines. 
Despite the setbacks and opposition to smallpox vaccination, the process continued 
throughout the 19th and 20th centuries, leading to a decrease in outbreaks in the developed world. 
By the end of World War II, western countries had all but gotten rid of the virus within their 
borders and the focus shifted to the developing world.
22 In 1958, the World Health Organization 
(“WHO”) first announced the goal of eradicating smallpox from the world. But it was not until 
1967 that the WHO seriously devoted its resources to this goal. Using a strategy of surveillance, 
isolation, and vaccination, the WHO finally achieved eradication in 1979.
23 Thanks to these 
national and international efforts, routine vaccination for smallpox is no longer necessary and the 
biggest concern about smallpox in modern times is that it might be used as a biological weapon, 
not that natural outbreaks will occur to claim lives.
24 
After Jenner developed the smallpox vaccine, other discoveries followed. Louis Pasteur 
created vaccines against anthrax, cholera, and virus-caused rabies in the late 19th century. Later 
on, vaccines for a variety of other diseases, including typhoid fever, tetanus, and diphtheria, were 
discovered.
25 Now, the CDC recommends a number of vaccines for children to receive, ranging 
from Hepatitis A and B to Varicella (commonly known as chickenpox).
26 Furthermore, states 
                                                             
22 Eyler, supra note 1, at 219. 
23 Id. at 219-20. 
24 PETER BARTON HUTT ET AL., FOOD AND DRUG LAW: CASES AND MATERIALS 896 (3rd ed. 2007) (noting that 
government officials are currently dealing with the threat of purposeful exposure of the population to smallpox as an 
infectious agent); Janie Parrino & Barney S. Graham, Smallpox Vaccines: Past, Present, and Future, 118 J. 
ALLERGY & CLINICAL IMMUNOLOGY 1320, 1320 (2006). 
25 Maurice R. Hilleman, Vaccines in Historic Evolution and Perspective: A Narrative of Vaccine Discoveries, 18 
VACCINE 1436, 1438 (2000). 
26 CDC, 2010 RECOMMENDED IMMUNIZATIONS FOR CHILDREN FROM BIRTH THROUGH 6 YEARS OLD (2010), 
available at http://www.cdc.gov/vaccines/events/niiw/2010/downloads/educ/parent-ver-sch-0-6yrs-508.pdf.  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have certain required vaccinations for children entering daycare or the school system.
27 The 
public’s participation in vaccination has helped dramatically to increase the survival rate for 
newborns and young children.
28 The medical community has also largely embraced vaccines and 
the hope of disease prevention that they offer, seeking solutions for the troubling diseases of the 
modern era such as tuberculosis, Hepatitis C, and HIV/AIDS.
29 
With all the benefits to be derived from vaccinations, a troubling development occurred 
in the late 1990s, which has had long-lasting repercussions. As noted, since the 1800s there have 
been members of the public who have expressed resistance to vaccination. Dr. Andrew 
Wakefield’s actions fueled that resistance in the modern era, giving it new life. In 1998, Dr. 
Wakefield, along with several other researchers, published a five-page paper in The Lancet, a 
well-known British medical journal, entitled Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific 
Colitis, and Pervasive Developmental Disorder in Children. While the name of the article may 
not have been particularly memorable, its consequences certainly were. According to Wakefield 
et al., development of behavioral disorders, namely autism, and intestinal abnormalities could be 
linked to the Measles, Mumps, and Rubella (“MMR”) vaccine.
30 Although other researchers 
quickly responded with their own studies challenging Wakefield’s findings, the damage was 
done. The idea that vaccines caused autism entered the public discourse, creating fear and anger 
that lingered long after Wakefield’s research had been rejected by the medical community. This 
paper seeks to explore the history and evolution of the vaccine-autism myth as well as its long-
term social consequences. 
                                                             
27 CDC, Vaccines: Requirements and Laws (May 3, 2010), http://www.cdc.gov/vaccines/vac-
gen/laws/default.htm#school. 
28 See supra note 4. 
29 Hilleman, supra note 25, at 1445. 
30 A. J. Wakefield et al., Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Developmental 
Disorder in Children, 351 LANCET 637, 637 (1998).  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Part One of the paper will discuss Wakefield and his research. Parts Two and Three will 
focus on the responses of the medical community and of the public with regard to the supposed 
connection between autism and vaccination. Part Four will deal with recent developments 
concerning Wakefield and his questionable research. Part Five will delve into the aftermath of 
the vaccine-autism myth and Part Six will cover the lessons to be learned from the controversy as 
well as possible future courses of action to undo the damage of the myth. 
I.  The Man and the Myth 
Andrew Wakefield, lead author of the 1998 article suggesting a link between autism and 
the MMR vaccine, is not a charlatan peddling magical cure-alls to an unsuspecting public; he has 
the credentials of a serious medical researcher. Born in England to a physician mother and a 
neurologist father, he studied medicine at St. Mary’s Hospital, ultimately choosing a career in 
gastrointestinal surgery.
31 He won a fellowship to study in Canada for a period of time before 
returning to the United Kingdom in the late 1980s, where he ended up working at the Royal Free 
Hospital in London.
32 At the age of thirty-two, he found the answer to what causes Crohn’s 
disease, something other researchers had been working on for decades.
33 Clearly, Wakefield was 
a capable researcher. And in that capacity, he began looking into autism and the MMR vaccine in 
1996.
34 Two years later, he published his findings. 
Wakefield’s research centers on twelve children between the ages of three and ten who 
initially had normal development but subsequently lost some acquired skills while gaining 
                                                             
31 Rebecca Smith, Andrew Wakefield - The Man Behind the MMR Controversy, TELEGRAPH (London), Jan. 29, 2010, 
http://www.telegraph.co.uk/health/healthnews/7091767/Andrew-Wakefield-the-man-behind-the-MMR-
controversy.html?sms_ss=email&at_xt=4d50aab6825e9169%2C0. 
32 Id. 
33 PAUL A. OFFIT, AUTISM’S FALSE PROPHETS: BAD SCIENCE, RISKY MEDICINE, AND THE SEARCH FOR A CURE 18 
(2008). 
34 Smith, supra note 31. 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gastrointestinal problems.
35 After describing the various diagnostic tests that were run on the 
children, Wakefield notes in the Results section of the paper that in eight of the children, the 
onset of problems had been linked by their parents to the MMR vaccine.
36 In these children, the 
average time between receiving the vaccine and developing behavioral symptoms was 6.3 days.
37 
For example, one child received a dose of the MMR vaccine when he was four-and-a-half years 
old. One day later, his mother noticed a “striking deterioration in his behavior[,]” which she 
linked to the vaccine.
38 The paper then moves into the Discussions section, where Wakefield et 
al. discuss possible causes of autism. Noting a connection between intestinal dysfunction and 
autism, Wakefield first mentions the “opioid excess” theory of autism, which links autism to 
digestive problems.
39 If the MMR vaccine causes these digestive problems, it would be a 
possible cause of autism as well. Following the discussion of the “opioid excess” theory, 
Wakefield et al. state that the MMR vaccine has been implicated as a possible cause of autism, 
though they clarify in a later paragraph that they have not actually proven such an association 
between the two.
40 
The 1998 paper did not definitively point to the MMR vaccine as the cause of autism and 
neither was Wakefield the first researcher to note a link between autism and vaccination. 
Another paper had been published two years earlier in which Dr. H. H. Fudenberg notes that 
autism may be due to adverse reactions to a live virus vaccine, although he limits the statement 
to those with a genetic predisposition to the disorder.
41 Taken on its own, then, Wakefield’s 
paper was not earth-shattering and did not make any strong statements about the MMR vaccine 
                                                             
35 Wakefield et al., supra note 30, at 637. 
36 Id. at 638. 
37 Id. 
38 Id. 
39 Id. at 640. 
40 Id. at 640-41. 
41 H. H. Fudenberg, Dialysable Lymphocyte Extract (DLyE) in Infantile Onset Autism: A Pilot Study, 9 BIOTHERAPY 
143, 146 (1996).  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and autism. However, Wakefield went one step further, participating in a press conference where 
he stated that he could no longer support the use of the MMR vaccine because he considered 
such use to be a “moral issue” in need of urgent investigation.
42 As Wakefield explained at the 
press conference, he believed the MMR vaccine led to autism by causing infection and 
inflammation of the intestine upon injection. Once the intestine was damaged, harmful proteins 
could pass through it and into the bloodstream, ultimately finding their way to the brain and 
damaging it.
43 And thus a myth was born. 
II.  The Medical Community’s Response 
The medical community responded quickly to Wakefield’s paper and his public 
comments. It is not possible to give a detailed account of every report that came out in the 
subsequent months and years refuting Wakefield et al.’s findings so only a sampling is given in 
the following pages. 
A.  Chen & DeStefano’s Contemporaneous Warning 
In the same issue of The Lancet where Wakefield et al. published their paper, Robert T. 
Chen and Frank DeStefano of the Vaccine Safety and Development Activity National 
Immunization Program (part of the CDC) submitted a brief piece of commentary urging caution 
in accepting Wakefield’s suggestion of a link between the MMR vaccine and autism.
44 Chen and 
DeStefano begin by pointing out that millions of people have been receiving the MMR vaccine 
since the 1960s without developing either bowel or behavioral problems, which demonstrates at 
the very least that even if the vaccine causes autism, it is an exceedingly rare occurrence.
45 
                                                             
42 Nick Triggle, Wakefield and Autism: The Story that Will Not Go Away, BBC NEWS, Jan. 28, 2010, 
http://news.bbc.co.uk/2/hi/health/8481583.stm. 
43 OFFIT, supra note 33, at 20-21. 
44 Robert T. Chen & Frank DeStefano, Commentary, Vaccine Adverse Events: Causal or Coincidental?, 351 
LANCET 611 (1998). 
45 Id. at 611-12.  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The authors then proceed to point out potential problems with Wakefield et al.’s research. 
They state that other researchers, “using more sensitive and specific assays,” have not made 
similar findings of the presence of vaccine viruses in patients with bowel problems.
46 In addition, 
Chen and DeStefano point out that given the number of children who are vaccinated with the 
MMR vaccine every year, often during the time when autism first manifests, it is inevitable that 
some children will be diagnosed with autism after vaccination even if the two events are not 
causally related. By specifically choosing patients in order to study the connection between the 
vaccine and bowel disorders, which Wakefield posits as a possible cause of autism, biased case-
ascertainment is occurring, which may exaggerate the association.
47 Finally, Chen and DeStefano 
take issue with the fact that Wakefield and his team did not complete “critical” virological 
studies in their patients to support their hypothesis linking bowel disorder to the MMR vaccine 
as a prerequisite for developing autism.
48 
In closing, Chen and DeStefano note that, as a historical matter, concerns about vaccine 
safety usually increase when the actual disease the vaccine prevents is no longer a threat because 
of the effectiveness of the vaccine while the number of adverse reactions attributed to the 
vaccine increases because of widespread use. Some of these attributions may also be false 
because developmental abnormalities often manifest around the same time that children get 
vaccinated.
49 Given all this, they argue that it is necessary to use “[e]ffective and credible 
systems” to evaluate vaccine safety so that causal and coincidental problems can be 
distinguished from each other. Otherwise, concerns about vaccines that are reported by 
                                                             
46 Id. at 612. 
47 Id. 
48 Id. 
49 Id. 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researches like Wakefield et al. “may snowball into societal tragedies where the media and the 
public confuse association with causality and shun immunization.”
50 Prophetic words. 
B.  Peltola et al.’s Fourteen Year Study 
A few short months later, The Lancet published another article about the MMR vaccine, 
bowel disease, and autism, based on a fourteen-year study by Heikki Peltola et al.
51 The study is 
based on data from Finland, which began a vaccination project in 1982 to eradicate MMR 
diseases in the country. Accordingly, all children in the country were given two doses of the 
vaccine, once at fourteen to sixteen months of age and again at six years of age. Any adverse 
reactions to the vaccine were then reported to the National Public Health Institute, which was 
responsible for overseeing the vaccine program.
52 
In order to determine whether or not there is a connection between the MMR vaccine and 
bowel disorder or autism, Peltola et al. begin by combing through the adverse reaction reports 
from 1982 through 1996 to look for any cases where children developed gastrointestinal 
problems after being vaccinated. Out of the approximately three million doses distributed, thirty-
one recipients of the vaccine developed gastrointestinal symptoms after vaccination.
53 The 
symptoms developed between twenty hours and fifteen days after receiving the vaccine, were 
relatively mild, and in all but one case, cleared up again within a week.
54 Most importantly, 
Peltola et al. report that they are unable to find a single case in which a child developed an 
autistic spectrum disorder after vaccination.
55 
 
                                                             
50 Id. 
51 Heikki Peltola et al., Research Letters, No Evidence for Measles, Mumps, and Rubella Vaccine-Associated 
Inflammatory Bowel Disease or Autism in a 14-Year Prospective Study, 351 LANCET, 1327 (1998). 
52 Id. at 1327. 
53 Id. 
54 Id. at 1327-28. 
55 Id. at 1328.  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C.  Brent Taylor et al.’s Alternative Approach 
While Peltola et al. scrutinize the immunization records of Finland and try to track down 
cases of autism that developed after receiving the MMR vaccine, Brent Taylor and his team of 
researchers take a different approach to testing whether the MMR vaccine is causally associated 
with autism. They start by identifying all children with autism born since 1979 in eight health 
districts in the United Kingdom and then look to see if there is a change in incidents of autism 
once the MMR vaccine was introduced in 1988.
56 Although Taylor et al. do find an increase in 
the incidence of autism in more recent years, they point out that the increase is not causally 
related to the MMR vaccine because use of the vaccine had plateaued at the time when instances 
of autism were on the increase.
57 Instead, the researchers postulate that the greater number of 
autism cases may reflect better training in the medical community to recognize the disorder 
and/or better recognition of higher functioning children who nonetheless are autistic.
58 
As part of their research efforts, Taylor et al. also investigate whether the time at which 
children were vaccinated with the MMR vaccine correspond in some way with the age at which 
autism was diagnosed. Their conclusion: age of diagnosis is not connected to whether or when 
the vaccine is given.
59 Specifically, regression in behavioral development in autistic children, 
which Wakefield et al. discussed at length in their paper, is not more common in the months after 
vaccination.
60 Taylor et al. do find that there is a peak in parents reporting the first signs of 
behavioral abnormality at eighteen months of age, which results in a clustering effect for 
reporting problems within six months of obtaining the MMR vaccine. However, the authors 
                                                             
56 Brent Taylor et al., Autism and Measles, Mumps, and Rubella Vaccine: No Epidemiological Evidence for a 
Causal Association, 353 LANCET 2026, 2026 (1999). 
57 Id. at 2028. 
58 Id. 
59 Id. 
60 Id. at 2029.  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attribute this effect to parents estimating the time of onset of behavioral abnormalities to eighteen 
months of age because they could not recall the actual time of onset.
61 Based on all of the data, 
Taylor et al. find no support for the hypothesis that the MMR vaccine is causally related to 
autism.
62 
After Taylor et al. published their paper in The Lancet, Wakefield wrote to the journal, 
criticizing the research on the basis of three perceived weaknesses. First, he takes issue with the 
case-series method by which Taylor’s team carried out the research, stating that it is not an 
effective way to identify a relationship between exposure and disease where the disease in 
question manifests gradually such that diagnosis does not occur immediately.
63 Second, 
Wakefield disapproves of the way Taylor et al. explained away the statistically significant 
increase in parents’ reported concern for their children’s behavior that occurred within six 
months of receiving the MMR vaccine.
64 But the biggest problem, according to Wakefield, is the 
fact that Taylor et al. failed to mention an MMR catch-up campaign launched in the United 
Kingdom in 1988 when the vaccine was first introduced. During the catch-up campaign, young 
children born prior to 1988 who had not received either the mumps or rubella vaccine were given 
the MMR vaccine instead.
65 Thus, children born in 1986 also received the vaccine and, more 
significantly, there was a dramatic increase in the development of autism beginning in 1986 as 
compared to previous years, which still hints at a possible connection between the two. Due to 
these perceived flaws, Wakefield cautions against accepting Taylor et al.’s research and ultimate 
conclusions.
66 
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D.  Kaye et al.’s Research Supporting Taylor’s Findings and Rejecting the Vaccine-
Autism Connection 
 
Along with Wakefield’s criticism of Taylor et al.’s work, The Lancet published a reply 
from Taylor and two other researchers defending their study.
67 They claim that Wakefield 
misinterpreted their data and results, ending with a statement that they continue to support their 
conclusion that there is no causal connection between the MMR vaccine and autism.
68 Soon after, 
James A. Kaye et al. published their own study on the temporal relation between the MMR 
vaccine and onset of autism, which supported Taylor et al.’s conclusion.
69 
Kaye et al. begin by identifying 305 British children who were diagnosed with autism 
between the years 1988 and 1999. They obtained information on these children’s medical history 
from the UK general practice research database, which has detailed information on vaccination 
history.
70 Out of these 305 children, the researchers focus in on 114 boys born between 1988 and 
1993 who were diagnosed with autism between the ages of two and five and conduct statistical 
analysis by annual birth cohort in order to determine the prevalence of autism.
71 Kaye et al. find 
that the annual incidence of autism in children increased from 0.3 per 10,000 people in 1988 to 
2.1 per 10,000 people in 1999.
72 In addition, the risk of autism among boys aged two to five 
increased nearly fourfold between 1988 and 1993. During this time, however, the rate of MMR 
vaccination remained constant at ninety-seven percent.
73 
After presenting the results of the statistical analysis, Kaye et al. discuss the implications 
of the data. Like Taylor et al., they point out that if the MMR vaccine is causally related to 
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autism, then the prevalence of autism should have plateaued shortly after the vaccine’s use 
became widespread. The fact that this is not the case speaks against a causal connection between 
the MMR vaccine and autism.
74 Also like Taylor et al., Kaye and his team posit that the increase 
in rates of autism may be due to increased awareness on the part of the medical community or 
changing diagnostic criteria.
75 
E.  Other Research Rejecting a Connection Between the MMR Vaccine and Autism 
As early as 1999, just a little over a year after Wakefield et al.’s study was published, 
certain members of the medical community were already calling for an end to research into the 
connection between autism and vaccination on the grounds that the alleged link had been 
disproved.
76 And yet, researchers continued to report their findings in subsequent years, perhaps 
in an attempt to combat the pervasive shadow that the myth cast upon the public’s conception of 
the MMR vaccine. 
In 2002, a study based on population data from Denmark was published in The New 
England Journal of Medicine.
77 Madsen et al. look at all children born in Denmark between 1991 
and 1998, obtaining information on the children’s vaccination status and any diagnosis of autism 
or autistic spectrum disorders. After analyzing the data, they conclude that there is no increase in 
the risk of autistic disorder among children who received the MMR vaccine.
78 Additional 
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evidence for the lack of a causal connection between the vaccine and autism comes from the fact 
that there is no temporal clustering of autism cases after immunization.
79 
Almost a decade after Wakefield’s initial paper, researchers were still publishing papers 
disproving the link. For example, Tokio Uchiyama et al. conducted a similar population-based 
study on the use of MMR vaccine in Japan, publishing their results in 2007.
80 The Japanese 
history with the vaccine provided a unique opportunity to test for a causal connection between it 
and autism. The vaccine was introduced into Japan in 1989, with the government recommending 
one dose to be given to children between twelve and thirty-six months of age. Only a few years 
later, in 1993, the government ceased extensive use of the MMR vaccine because a few cases of 
aseptic meningitis developed after immunization.
81 Thus, if the MMR vaccine caused autism, 
incidents of the disorder should have increased shortly after the vaccine was introduced in 1989 
and then decreased once the vaccine was no longer in widespread use. To test the link between 
the MMR vaccine and autism, Uchiyama et al. first compare the presence of regressive 
symptoms in autistic children who received the MMR vaccine and those who did not. They also 
look at the proportion of children who had regressive symptoms before, during, and after the 
MMR vaccine’s use in Japan.
82 They find no significant difference in regression between those 
children who received the MMR vaccine and children who did not. Furthermore, there is no 
significant increase in the general incidence of regression in the period when the MMR vaccine 
was used as compared to the years before and after it was administered.
83 
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An added bonus of the Uchiyama study is the probable lack of bias in clinicians and 
parents who participated in the research. Unlike in Europe and the United States, the alleged link 
between the MMR vaccine and autism was never publicized in Japan. In addition, by the time 
Wakefield published his first paper and began communicating his concerns to the public, the 
MMR vaccine had already been taken off the shelf in Japan.
84 Thus, in answering questions 
about regressive symptoms, parents were not thinking about any possible connection between 
those symptoms and their children’s immunization history, adding credibility to their answers. 
As the next part of the paper reveals, it was public awareness of the alleged vaccine-autism 
connection in the Western world that gave life to the myth, ultimately leading to unfortunate 
consequences. 
III.  The Public’s Response 
As many researchers, including several mentioned in Part Two of the paper, have noted, 
the number of children diagnosed with autism and autistic-spectrum disorders has been 
increasing in recent times.
85 Autism, depending on severity, can be a devastating disorder for 
both the children who suffer from it and their parents. Autistic children predominantly suffer 
deficits in the realm of communication, neither responding to others nor expressing themselves 
verbally.
86 More severe symptoms of the disorder may include banging one’s head against a wall 
or slapping oneself.
87 Children may also lash out at their surroundings, destroying entire 
households.
88 In rare instances, parents of autistic children have become so overwhelmed with 
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the behavioral difficulties presented by their children, they have killed them in order to escape.
89 
Given the severe toll that the disorder can take on afflicted families, the amount of publicity 
generated by Wakefield’s research becomes more understandable. An identifiable cause may 
bring researchers one step closer to a cure. At the least, it provides a target for parents’ 
frustrations and supposedly answers the question of “why is my child sick?” 
A.  Popular Media 
The popular press was quick to publicize Wakefield’s findings. The Guardian and the 
Daily Mail both published articles about the alleged link between the MMR vaccine and autism 
at the same time that The Lancet published Wakefield’s article.
90 While neither article 
definitively linked the vaccine and autism, and both were quick to point out that there was no 
medical consensus about the finding, both also quoted Wakefield’s remarks from his press 
conference, where he expressed his discomfort with continued use of the MMR vaccine. In the 
days, months, and years that followed, newspapers kept the story in people’s minds, providing 
periodic updates on the medical debate over the vaccine and playing up the controversy.
91 And 
sometimes, the popular press published wrenching stories of parents whose children had a 
negative reaction to the MMR vaccine even though doctors ruled out the vaccine as a cause of 
the reaction.
92 Such stories served to increase both the fear of the MMR vaccine and the impact 
of the controversy on the public. 
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Later on, when revelations about Wakefield’s research and potential conflicts of interest 
came to light, casting doubt on his findings, the newspapers eagerly reported on these 
developments as well.
93 Some stories cast Wakefield as a hero fighting against a medical 
community and government that did not care about children’s safety while others reported that 
Wakefield committed outright fraud.
94 Regardless of the portrayal of Wakefield and the 
increasing criticisms of his study, the media had done its damage. The public did not necessarily 
remember or care about Wakefield himself but it did remember the underlying theme of his 
message: MMR vaccines may cause autism.
95 And this broader theme generated problems that 
played themselves out in multiple arenas. 
B.  Celebrity Endorsement 
As with many other products and causes, Wakefield’s research soon found itself a 
celebrity endorser who would help spread the message that vaccines pose a danger and may 
cause autism. Jenny McCarthy, one-time Playboy model turned actress and author, became a 
spokesperson for the vaccine-autism controversy, giving voice to the concerns of hundreds and 
thousands of parents, using her fame to help spread a “beware of vaccinations” message. Her 
passion and zeal in this role came from her own experiences with her son, Evan, who was 
diagnosed with autism after having multiple seizures at the age of two.
96 
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  After Evan was diagnosed, McCarthy began doing research on autism, eventually 
stumbling onto a website that claimed autism is reversible. In reading the stories from other 
parents on the site, McCarthy came to believe that the MMR vaccine was the cause of her son’s 
problems.
97 She also became convinced that her ultimate calling was to publicize the information 
she had learned about autism and share it with other mothers.
98 McCarthy herself has stated, “I 
will work my ass off, raising awareness for autism and banging down doors to get answers.”
99 As 
part of working to raise awareness, McCarthy has appeared on television shows such as Oprah, 
20/20, and Larry King Live, where she has repeatedly voiced her concerns about vaccines and 
autism.
100 For example, in 2008, McCarthy went on Larry King Live to speak about autism and 
said that vaccines play “the largest role” in triggering autism in children.
101 While McCarthy did 
not go so far as to claim that children should not be vaccinated at all, she expressed concern over 
the number of vaccines and the schedule for receiving them.
102 When asked if her views on 
autism were backed by scientific research, McCarthy stated quite frankly that her views were 
based on anecdotal information from parents of autistic children that she had met over the years, 
which she equated to science-based information.
103 
  And this is the power of McCarthy: while the scientific and medical communities may 
run experiments and publish findings time and time again, all of which find no causal connection 
between autism and vaccines, McCarthy gives voice to the parents who struggle daily with 
raising autistic children, who are trying desperately to understand why their children are sick. 
Dry science and medical studies are no match for the heart-wrenching stories of children who 
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seem perfectly fine one day only to undergo dramatic developmental and behavioral changes 
shortly after receiving the MMR vaccine. Until the scientific community can provide a definitive 
alternative explanation for what causes autism, there will be parents who rely on anecdotes to 
perpetuate the vaccine-autism myth first publicized by Wakefield. McCarthy, as the most famous 
of such parents, provides an illustration of how difficult it may be for science to counter the myth: 
as reports about Wakefield’s questionable research methods surfaced and mounting medical 
evidence rejected a connection between autism and vaccination, McCarthy stood by Wakefield, 
claiming that the concerns about Wakefield were simply “the allegations of a single British 
journalist.”
104 Instead of seeing the criticism of Wakefield’s work as signaling the end of the 
vaccine-autism debate, McCarthy has become even more determined to look into how vaccines 
cause autism and “fight for the truth about what’s happening to our kids.”
105 
C.  Litigation 
Given the conviction some parents have that vaccines are responsible for their children 
developing autism and the expenses associated with raising autistic children, it comes as no 
surprise that angry parents filed lawsuits seeking compensation. In the United States, claims for 
harm from vaccines are heard in a special Vaccine Court, created through the federal Vaccine 
Injury Compensation Program (“VICP”). VICP itself was a response to another vaccine scare 
involving the diphtheria-pertussis-tetanus (“DPT”) vaccine in the 1980s.
106 As with the MMR 
vaccine, the concerns about the DPT vaccine turned out to be unfounded. Despite the scientific 
evidence, though, sympathetic juries sometimes awarded significant damages to plaintiffs.
107 The 
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combination of increased litigation and difficulty in obtaining liability insurance threatened to 
drive vaccine manufacturers out of the business of making vaccines.
108 In an effort to continue 
protecting the population through vaccination, Congress created VICP with the goal of 
streamlining vaccine claims while protecting manufacturers from massive payouts for those rare 
instances where a patient suffers a severe adverse reaction to a vaccine. 
Under the VICP, a plaintiff alleging harm from a vaccine needs to show some causal 
connection between the administered vaccine and the harm suffered. An advisory committee 
keeps an up-to-date list of known side effects of each vaccine and if a child suffers from one of 
these recognized side effects shortly after receiving the vaccine, causation is presumed.
109 If a 
child suffers from an adverse effect that is not on the list, however, it is up to the child’s family 
to show that the vaccine was the cause of the adverse reaction.
110 Assuming that causation is 
proven, a plaintiff can receive compensation for medical expenses, lost future income, and up to 
$250,000 for pain and suffering.
111 To free vaccine manufacturers from having to pay the awards, 
the VICP created a trust, funded by a fee on each vaccine administered.
112 
Autism has not been listed as a recognized adverse effect for any vaccines. Thus, parents 
seeking compensation through the VICP have the burden of showing the connection between the 
vaccines their children received and autism. To win, parents have to show that the vaccine was a 
substantial factor in causing the harm and the link must be supported by “reputable medical or 
scientific explanation.”
113 The potential difficulty of this burden, especially given the lack of 
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consensus about the medical evidence, did not deter parents from filing claims. Between 
2001and 2007, over five thousand autism claims were filed with the Vaccine Court.
114 Indeed, in 
the first decade of the 21st century, approximately seventy-five percent of the cases filed under 
the VICP have been autism-related.
115 
Given the staggering number of autism claims, an “Omnibus Autism Proceeding” 
(“OAP”) was developed whereby the Vaccine Court would first look to the evidence and decide 
whether vaccines can cause autism in general. If the answer to this first inquiry was in the 
affirmative, then the Vaccine Court would proceed on to adjudicating individual cases.
116 The 
OAP began collecting general information in 2002, eventually amassing thousands of pages of 
medical evidence and expert testimony. Finally, in 2007, several test cases involving the issue of 
general causation were presented to the three special masters who were in charge of the OAP.
117 
The first three test cases all involved claims that the MMR vaccine, either on its own, or in 
combination with thimerosal, a mercury-based preservative sometimes put into vaccines, caused 
autism in the plaintiff children.
118 In all three cases, the special masters held that the plaintiff 
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parents failed to demonstrate that the MMR vaccine was the cause of their children’s autism.
119 
These decisions were upheld on appeal.
120 
In non-autism related claims under the VICP, parents who failed to demonstrate a causal 
connection generally did not attempt to obtain compensation in some other manner.
121 However, 
in the autism context, there is reason to believe that parents will not give up so easily, despite the 
medical evidence and court decisions to the contrary. First, these parents are well-organized and 
have the support of lawyers as well as several prominent congressmen.
122 Second, and more 
importantly, they absolutely believe in their claims, regardless of what the medical data shows. 
Those who believe in the vaccine-autism connection have dismissed the adverse findings of the 
special masters, claiming that the OAP arrangement will never result in a fair ruling for 
plaintiffs.
123 That this criticism is used to reject the Vaccine Court’s proceedings, despite the fact 
that it was the plaintiffs’ attorneys who initially proposed the omnibus proceeding,
124 
demonstrates how strongly some parents feel about the vaccine-autism connection and how 
difficult it may ultimately be to put an end to the controversy. 
D.  Congressional Action 
Courts were not the only governmental body that became involved in the vaccine-autism 
debate. Beginning in 2000, Congress conducted several hearings on possible links between 
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vaccines and autism. These hearings before the Committee on Government Reform were chaired 
by Congressman Dan Burton of Indiana. At the first hearing, Congressman Burton opens the 
meeting with stories about his own grandchildren’s negative experiences with vaccines. 
According to Burton, his granddaughter stopped breathing and had to be rushed to the hospital 
after receiving the Hepatitis B vaccine while his grandson became autistic after receiving a series 
of vaccines.
125 Burton then launches into a discussion on the possible link between autism and 
vaccination, stating that forty-seven percent of parents who provided pictures of their children 
for an autism rally felt that autism was linked to vaccines.
126 Although Burton makes clear that 
he is not anti-vaccinations and that he knows not all cases of autism are caused by vaccines,
127 
the record of the hearing suggests that he was far from impartial on the issue. 
It must be noted as an initial matter that many of those invited to testify in person, 
including parents of autistic children and Wakefield himself, were more accepting of the 
vaccine-autism connection while many of the individuals and groups who were not invited to 
testify were those who submitted letters and statements expressing concern that the hearing 
would perpetuate the false perception that vaccines cause autism.
128 Brent Taylor, whose 
research contradicting Wakefield was discussed earlier, also testified at the hearing, presenting 
his evidence to the Committee. After Taylor concludes his statement, Burton calls a witness from 
the audience to cast doubt on the credibility of Taylor’s research method, a move that goes 
against the rules of the Committee.  This unusual procedure prompts Congressman Waxman of 
California to comment that Burton’s act of calling an unexpected witness just because Taylor did 
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not present testimony that fit with Burton’s preconceived notions turned the hearing “more into a 
circus than a genuine fact-finding opportunity.”
129 
After justifying the calling of the unexpected witness on unexplained “extenuating 
circumstances,”
130 Burton goes on to express concern with the fact that another expert witness 
who denied the vaccine-autism connection was funded by Merck, which Burton thinks hints at a 
conflict of interest or bias towards vaccines.
131 Based on the way the hearing is handled, (i.e., 
inviting parents who link vaccines to the development of autism to speak, calling unanticipated 
witnesses to question the methodology of researchers who disagree with Wakefield’s 
conclusions, and not inviting experts from various medical and immunological associations who 
may deny a causal connection between autism and vaccination) Waxman expresses concern that 
the entire hearing is meant to establish a particular point of view, namely Burton’s view that 
vaccines are linked to autism.
132 
One year later, Burton chaired another hearing on the increased rates of autism.
133 After 
retelling the story of his grandson’s descent into autism shortly after being vaccinated,
134 Burton 
discusses the recent report released by the Institute of Medicine’s (“IOM”) Committee on 
Immunization Safety Review on the MMR vaccine. According to Burton, while the report itself 
does not conclusively prove or disprove a link between the vaccine and autism, various media 
outlets had all begun to report that there was no connection, which Burton views as a 
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“disservice . . . to the American people.”
135 Throughout the rest of the hearing, Burton time and 
time again questions various aspects of both the IOM Committee and its report findings. 
First, when the chairwoman of the IOM Committee, Dr. Marie McCormick, testifies 
before the congressional Committee and states that the MMR vaccine has not been shown to be a 
contributing factor in autism, Burton pushes back again and again, asking if McCormick knows 
in absolute terms that this is the case,
136 getting himself quite worked up in the process.
137 The 
problem with Burton’s reasoning is that autism is a disorder whose origins are currently 
shrouded in mystery. That the Review Committee is unwilling to say definitively that vaccines 
do not ever play any part in the development of autism is a far cry from saying that vaccines 
cause autism. Unfortunately, it is this latter message that Burton seems most enthusiastic about 
spreading, regardless of its veracity. 
After the heated exchange with McCormick, Burton goes on to question whether or not 
the members of the IOM Committee had conflicts of interest in terms of funding from 
pharmaceutical companies. When the representative from the IOM, Ms. Stoiber, testifies that all 
Committee members were carefully scrutinized to make sure that none of them were being 
funded in any way by the pharmaceutical companies, Burton shifts the attack. He first tries to 
raise doubts about IOM’s methods for choosing reviewers for its report, suggesting that only 
reviewers who were skeptical of the vaccine-autism link were chosen.
138 After Stoiber repeatedly 
assures Burton that reviewers are chosen from all sides of the issue,
139 Burton again raises the 
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issue of funding, asking if any of the reviewers were being funded by pharmaceutical 
companies.
140 He raises this point even though Stoiber informs him that reviewers’ comments are 
given anonymously, that several reviewers were sympathetic to the vaccine-autism link, and that 
reviewers have no ability to change the IOM report in any way.
141 Having been rebuffed again, 
Burton raises a third alleged problem: that some of the IOM Committee members worked at 
universities that, in some way, received funding from the pharmaceutical companies.
142 When 
Stoiber responds that the IOM scrutinizes only the individual Committee members and the 
funding their labs receive,
143 Burton finally seems satisfied that he has discovered a problem 
with the IOM report. Interestingly, Burton never demonstrates much concern with either the 
direct or indirect funding of those who testified in favor of the vaccine-autism connection. As 
discussed in the next section of the paper, he should have been far more concerned about 
Wakefield’s financial motivations than the attenuated chain of financial bias he tries to create 
between some IOM Committee members, the universities where they are employed, and the 
pharmaceutical companies. 
As chairman of the House Committee on Government Reform, Burton convened multiple 
hearings on autism and vaccines. As Waxman notes in his opening remarks at yet another such 
hearing in 2002, Burton’s hearings had the positive effect of drawing more attention to vaccine 
safety, prompting researchers to devote attention to the issue.
144 And time after time, scientists 
conducting research and expert panels reviewing that research concluded that vaccines are 
safe.
145 Unfortunately, though, Burton has not accepted that research; instead, he has convened 
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additional hearings, “repeatedly provid[ing] a forum for unsubstantiated allegations about 
vaccine safety that have alarmed and confused parents.”
146 At the same time that evidence of 
vaccine safety has grown, concerns about their safety have also grown, possibly having 
detrimental effects on immunization rates.
147 Until researchers discover what exactly causes 
autism, it may be impossible for scientists to say conclusively that vaccines play no role 
whatsoever in the disorder. However, the fact that researchers cannot prove a negative fact with 
one hundred percent certainty should not be used to justify continued congressional hearings into 
the alleged vaccine-autism link. Continued congressional attention to this largely disproved link 
may play up the controversy in the minds of the public, perpetuating unfounded fears about 
vaccines. 
IV.  Problems with Wakefield and his Research 
As alluded to in the discussion of Burton’s congressional hearings, his fear that 
opponents of the vaccine-autism connection may have been biased for financial reasons was 
more properly directed at Wakefield. After his 1998 paper was published, it came to light that 
Wakefield had conflicts of interest that cast doubt on his findings. In the end, The Lancet would 
retract Wakefield et al.’s 1998 paper and Wakefield himself would be stricken from the United 
Kingdom medical register. 
In 2007, the General Medical Council (“GMC”) of the United Kingdom launched an 
investigation into Wakefield’s conduct that lasted until 2010. Ultimately, the GMC panel found 
that from the very beginning, Wakefield had a financial conflict of interest. As the panel 
explained, two years before he published his 1998 paper, Wakefield was contacted by Richard 
Barr, a solicitor who was interested in bringing a lawsuit against the manufacturers of the MMR 
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vaccine. In order to have a legitimate claim, Barr needed Wakefield to provide evidence that the 
vaccine had harmed recipients.
148 In exchange for his assistance, Wakefield received two 
payments of £25,000 (approx. $40,000) from the Legal Aid Board, which was helping to fund 
Barr’s lawsuit.
149 Later that same year, Wakefield submitted an application to the ethics 
committee of the Royal Free Hampstead National Health Service (“NHS”) Trust seeking 
approval to conduct research into a connection between the MMR vaccine and digestive 
disorders, the possible harm Wakefield was documenting for Barr’s lawsuit and the topic of his 
1998 paper.
150 In his application, Wakefield did not disclose either his connection with Barr’s 
lawsuit or the funding he was receiving from Barr, The GMC concluded that this nondisclosure 
was contrary to Wakefield’s responsibilities and deprived the Royal Free ethics committee of 
material information that would have aided it in determining the ethical implications of his 
proposed research.
151 
A similar nondisclosure occurred in the published version of the 1998 paper. There, when 
discussing how the study was funded, Wakefield et al. only credit the Special Trustees of Royal 
Free Hampstead NHS Trust and the Children’s Medical Charity, saying nothing about Barr’s 
potential lawsuit and the £50,000 Wakefield had received from the Legal Aid Board to help Barr 
find a connection between the MMR vaccine and injury to children.
152 This omission was 
actually noted by Barr, who admitted to funding The Lancet research, when he first saw the 
article.
153 In the years that followed, Wakefield would be paid a total of over £400,000 (over 
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$600,000) in fees by the Legal Aid Board and Barr for his work.
154 If Burton believes that a 
researcher may be tainted because the university he works for receives funding in some capacity 
from pharmaceutical companies, then the fact that Wakefield was directly being paid to find a 
problem with the MMR vaccine should raise serious concerns about his objectivity and 
trustworthiness. 
Such concerns about objectivity would not be unfounded. Aside from the funding issue, 
the 1998 paper also had problems relating to its research. First, Barr sent out a newsletter to his 
clients, telling them to contact Wakefield if their children had certain symptoms possibly related 
to Crohn’s disease. In the same newsletter, Barr wrote that Wakefield had “depressing views 
about the effect of vaccines on the nation’s children.”
155 Thus, Wakefield was able to choose test 
subjects from a very specific pool of potential applicants already predisposed to demonstrating a 
connection between vaccines and adverse health problems. In contrast, his 1998 paper describes 
the patients in his study as having been “consecutively” and “self-referred” to the 
gastroenterology department of the Royal Free hospital,
156 The GMC concluded that this 
language was irresponsible, misleading, and contrary to Wakefield’s duty to provide accurate 
information in his publication because it implied routine referrals to the Royal Free Hospital 
when, in reality, Wakefield was actively involved in seeking out the children for his study.
157 
The GMC also criticized Wakefield’s response to a letter to The Lancet that raised a possible 
selection bias in his study. By replying that all the children had been referred through normal 
channels on the merits of their symptoms, Wakefield further acted in a dishonest and 
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irresponsible manner.
158 These findings by the GMC were cited by The Lancet when it issued a 
formal retraction of Wakefield et al.’s 1998 paper.
159  
 In addition to the financial conflict of interest and dishonesty regarding the subject 
selection process, Wakefield was also guilty of falsifying data for his study. Of the twelve 
children that Wakefield studied for his 1998 paper, he reported that six of them had three key 
features supporting a connection between the MMR vaccine, gastrointestinal problems, and 
regressive autism. A comparison with the actual NHS medical records of the children, however, 
shows that none of the children in the study had all three features.
160 For example, a crucial link 
in Wakefield’s theory is that the onset of symptoms and behavioral changes in children occurred 
very shortly after receiving the MMR vaccine. Indeed, in his study, he reports that the average 
length of time between vaccination and behavioral abnormalities for eight of the children was 6.3 
days.
161 But actual NHS records indicate that, at most, only two of the children experienced onset 
of symptoms shortly after receiving the MMR vaccine.
162 For the rest of the children, many had 
been documented as having developmental problems before receiving the MMR vaccine.
163 
Based on this evidence, it seems clear that Wakefield had an agenda when he began his research 
in 1996—to link the MMR vaccine to some kind of injury in its recipients. The agenda was 
based on Wakefield’s financial interest in a lawsuit against MMR manufacturers. In pursuit of 
the agenda, Wakefield was willing to falsify research data. The problem with Wakefield’s 
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actions, as the GMC investigative panel found, was that Wakefield should have known his paper 
would have major public health implications such that he was under a duty to make sure that the 
factual information in the publication was true and accurate.
164 
The GMC investigation also concluded that Wakefield acted unethically with regard to 
the children in the original study. In the process of conducting his research, Wakefield subjected 
children in the study to various tests, including colonoscopies, lumbar punctures, and various 
blood and urine tests, just to name a few procedures. According to the GMC, Wakefield caused 
the children to undergo investigative procedures for research that did not have the approval of 
the Royal Free ethics committee.
165 Furthermore, and perhaps even worse, he acted in a manner 
that was contrary to the clinical interests of the children.
166 Wakefield tried to defend himself on 
the ground that he was only acting as an administrator, but the GMC determined that he was the 
one who actually ordered the investigations.
167 
Based on the breadth of Wakefield’s misconduct as documented by the GMC 
investigative committee, a Fitness to Practice Panel found Wakefield guilty of serious 
professional misconduct.
168 When it came time to decide on an appropriate sanction for 
Wakefield’s conduct, the Fitness to Practice Panel concluded that the totality of Wakefield’s 
transgressions merited the severest punishment possible: being erased from the medical register. 
The severe response was also seen as necessary to protect patients, given Wakefield’s “continued 
lack of insight as to his misconduct.”
169 And indeed, in an interview he gave after being struck 
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off the register, Wakefield stated that the outcome of the hearing was a foregone conclusion due 
to government pressure and that he would continue his research.
170 One can only hope that any 
future research he conducts will not be found to suffer from serious ethical violations. 
V.  Aftermath of the Myth 
After Wakefield published his paper, the public began losing faith in the MMR vaccine, 
despite multiple studies refuting Wakefield’s hypothesis and efforts by various health agencies to 
publicize the evidence contradicting Wakefield. Lost confidence translated into decreased 
vaccination rates, which allowed measles to make a comeback. In 2006, Britain suffered from 
“its worst measles outbreak since the MMR jab was introduced.”
171 A teenage boy actually died 
after contracting the disease; the first death from measles in Britain in fourteen years.
172 The 
upward trend continued in 2007, with 990 reported cases of measles, and in 2008, with 1348 
cases.
173 Back in 1998, the year when Wakefield’s paper was published, there were only 56 cases 
in England and Wales.
174 The United States also experienced increased measles cases, although 
the vaccination rate remained relatively high.
175 Despite the fact that medicine has come a long 
way since the pre-vaccine days, measles can still be quite serious, especially because doctors are 
now unfamiliar with the disease, thanks to the MMR vaccine’s effectiveness.
176 Potentially fatal 
complications that can develop from the measles include pneumonia, hepatitis, and swelling of 
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the brain.
177 Short of death, measles may also cause severe chronic dementia
178 or blindness in 
rare cases.
179 It is unfortunate that some children now risk developing these serious 
complications because of Wakefield’s actions. 
Besides the increase in measles cases, there have also been other long-term negative 
consequences from Wakefield’s theory. First, his research has contributed to growing fears of 
vaccines in general, serving as a springboard for new theories about vaccines and autism. As the 
MMR-autism link began to crumble, those who were skeptical of vaccines introduced a new idea 
for how vaccines caused autism: thimerosal. Thimerosal is a preservative derived from mercury 
that is added to vaccines to prevent multi-dose vaccine vials from being contaminated by bacteria. 
Multi-dose vials help keep down the cost of vaccines by reducing expenditures on packaging.
180 
Mercury itself may do severe damage to the nervous system and, as the hypothesis went, the 
mercury derivative in vaccines could be linked to autism, which manifested the same symptoms 
as mercury poisoning.
181 Eventually, just like the MMR vaccine-autism hypothesis, the 
thimerosal-autism hypothesis fell apart. The IOM reviewed all available data and concluded that 
“the evidence favors rejection of a causal relationship between thimerosal-containing vaccines 
and autism.”
182 More recently, the claim has become that the sheer number of vaccines and the 
multitude of ingredients in vaccines together, somehow, are causally connected to autism.
183 
These varying theories about how vaccines cause autism have had the unfortunate effect 
of creating long-lasting distrust of vaccines. For example, one recent study found that one in four 
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parents in the United States believes that some vaccines cause autism in children.
184 Such fears 
have contributed to parents’ decisions not to vaccinate their children against certain diseases.
185 
The obvious problem with this is that children then become unprotected from diseases that can 
also cause serious problems. It is true that the IOM Committee charged with reviewing vaccine 
safety has been unable to definitively rule out a causal connection between autism and vaccines, 
as Congressman Burton was eager to point out, but the great weight of the evidence disfavors the 
connection. That there may be some interplay between vaccines and autism in very rare instances, 
however, does not warrant widespread changes in vaccination policy. After all, vaccines are 
known to cause serious adverse reactions in very rare instances, but on the whole, government 
health agencies, in creating recommended vaccine schedules for their citizens, have determined 
that the overall benefits from large-scale vaccination outweigh the risk posed by those rare cases 
where serious problems develop. 
In addition to decreased vaccination, the vaccine-autism controversy has had the negative 
consequence of diverting precious resources away from autism research. There has been an 
increase in autism rates in recent years, with conservative estimates indicating that one in five 
hundred children has the disorder.
186 For parents who have autistic children, living with them can 
be “hell,” as the children lash out at their surroundings during outbursts.
187 Moreover, the costs 
of raising autistic children can be astounding. One study from the Massachusetts Institute of 
Technology found that the cost for raising an autistic child from birth to seventy years is between 
$3.5 to $4 million, ninety percent of which is for medical care and assistance.
188 Clearly, autism 
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is a serious and growing problem that requires the attention of the medical community. However, 
resources are not unlimited; whatever resources are spent on disproving the vaccine-autism myth 
then become unavailable for more promising studies into the actual causes of the disorder. As 
Congressman Waxman, whose own district has a new diagnosis of autism every three hours, has 
noted, given the finite resources available as well as the medical consensus, it no longer makes 
sense to continue to disprove the vaccine-autism myth.
189 But as long as vaccine myths persist, 
scientists will have to act defensively, dedicating their efforts to disproving those myths, rather 
than proactively studying autism itself. 
VI.  Lessons for the Future 
If public confidence in vaccines is to be restored and the myth laid to rest, it is necessary 
both to understand how the myth has persisted despite copious evidence refuting it and to 
address difficult questions about individual versus public health. First, as to the myth’s 
persistence, the importance of both the media and the Internet cannot be discounted. As detailed 
in Part Three of the paper, the media was a key player in spreading the myth to the public and in 
keeping the myth alive by publishing further articles with research updates,
190 by producing 
television shows about the controversy,
191 and, in later years, even after the myth had largely 
been rejected, by continuing to give voice to the myth’s supporters in the name of balanced 
journalism.
192 
                                                             
189 See One-Year Update Hearing, supra note 133, at 224. 
190 E.g., Beezy Marsh, New Evidence ‘Shows MMR Link to Autism,’ DAILY MAIL (U.K.), Aug. 9, 2002; Sarah 
Boselely, MMR Links to Autism Dismissed by Huge Study, GUARDIAN (U.K.), Feb. 5, 2008. 
191 OFFIT, supra note 33, at 22-23 (discussing a docudrama that aired in Britain in 2003, Hear the Silence, about 
Wakefield’s struggle to bring his research to the attention of the public, including a supposed plot by public health 
officials to discredit his work as well as intimidation from the drug companies). 
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In addition to the media coverage, the Internet has also been critical to the myth’s 
perseverance. While the media may pique parents’ interest, it is the Internet that can serve as the 
provider of vast amounts of (mis)information. For example, Jenny McCarthy, in trying to treat 
her son’s disorder, frequently went onto Google to find information. She goes so far as to state at 
the beginning of her book that she “should have a doctorate in Google research, what with the 
time [she] spent online trying desperately to understand what was happening to [her] baby.”
193 
Researching possible causes and treatments for a child’s health problems is not problematic in 
and of itself. The problem with conducting that research on the Internet, however, is that 
incorrect information may be presented to the researcher. The Internet is a great equalizer: 
anyone can put their theories out there for the public to review. Unfortunately, with so many 
different speakers on the Internet, those with actual expertise become just another voice, another 
opinion, and not necessarily the one given the greatest weight. And once a theory, or in this case 
a myth, is introduced to the world through the Internet, it becomes impossible to take it back, 
even if the theory itself turns out to be incorrect. 
All this is not to say that the media and the Internet are the enemies of those who are 
fighting to put the vaccine-autism myth to rest. Both are tools that can be used to aid the cause, 
but they must be used effectively. Parents of autistic children have been very successful at using 
the Internet to create networks and to share their stories. And those stories can be very 
compelling. When thousands of parents each tell a similar story of their children getting 
vaccinated and suddenly regressing behaviorally, no matter what the science demonstrates, it is 
difficult to disregard those stories. In a 2010 interview for a Frontline documentary about the 
vaccine-autism controversy, J.B. Handley, co-founder of Generation Rescue, Jenny McCarthy’s 
autism organization, and father to an autistic child, stated quite frankly: 
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I don’t give a [expletive] about what the MMR said. My kid got six vaccines in one day, 
and he regressed. You don't have any science that can show me that the regression wasn't 
triggered by the six vaccines. What the parents are saying is, “I went in for a vaccine 
appointment. My kid got six vaccines, and they regressed.”
194 
 
Given this kind of strong response, it becomes clear that just making scientific data available to 
the public through the media and the Internet is not enough. In addition, researchers and the 
medical profession also need to present their evidence in a compelling manner that engages 
parents and taps into parental concerns about their children’s welfare and safety. Such an 
approach may seem to go against the fact-driven nature of science, but it may be necessary in 
order to use media outlets successfully to spread the message. 
  Part of the problem for the medical community in making a compelling case comes from 
the very success of vaccines. The mothers of this generation have not seen firsthand the 
devastation that the diseases their children are vaccinated against can cause. They have, however, 
become more and more aware of autism, especially as rates of diagnosis have skyrocketed in 
recent years. Given this knowledge differential, parents’ risk assessment may be skewed against 
vaccines. As Arthur Caplan, a bioethicist at the University of Pennsylvania, points out, “one of 
the bitter ironies of vaccination is it carries with it the problems of its own success. . . . Many 
parents are not thinking about the risk side of disease because they don't see those diseases.”
195 If 
the medical community wants to restore faith in vaccines in a post vaccine-autism myth world, it 
has to address this problem somehow, preferably before the problem solves itself through 
decreased vaccine rates and reoccurrences of these diseases. 
One place to start may be to take more time to explain vaccines to parents, and more 
importantly, the dangers of the diseases those vaccines are meant to prevent. This kind of 
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dialogue may be especially important in an age where the Internet allows people to access 
medical information and self-diagnose, increasing their ability to participate in making medical 
decisions. One complaint some parents who are skeptical of vaccines have against the medical 
community is that their concerns are dismissed out of hand and may even anger health 
workers.
196 Such a response alienates parents and creates a distance between the patient and the 
physician. Instead of shutting down discussion before it can even begin, physicians should take 
the time to talk with their patients and address their concerns, even if the physicians believe 
those concerns are not based on legitimate science. In the information age, members of the health 
profession need to realize that they can no longer simply mandate a course of treatment and 
expect their patients to accept that mandate on the assumption that doctors know best. Instead, 
physicians have to take the extra step of demonstrating why they know best, using the 
opportunity to clear up any misconceptions patients may have about the prescribed treatment. 
  Another conversation that has to take place between the medical community and the 
public involves individual choice versus the public welfare. This is a discussion that is overdue 
in the wake of the vaccine-autism controversy. The problem is that, for many parents, 
vaccination is seen as a personal choice rather than something to be mandated by the government. 
For the government, though, vaccination plays a crucial role in maintaining a healthy citizenry. 
Specifically, vaccines, if effectively administered, lead to herd immunity. Herd immunity is an 
indirect benefit of vaccination that impedes the ability of a disease to spread. When the majority 
of the population is vaccinated, the virus cannot find suitable hosts, and may thus die out.
197 This 
is what happened with the smallpox virus. As the level of herd immunity increases (i.e., more 
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people are vaccinated), the rate of transmission decreases.
198 This secondary benefit of 
vaccination may be particularly important for protecting vulnerable members of the population 
who, because of underlying health issues, age, or some other condition, cannot be vaccinated 
themselves. 
From a public health perspective, then, it makes sense to vaccinate as many in the 
population as possible. For individual mothers, however, their children come first. And if they 
have any concerns about vaccines, which many do in the wake of the vaccine-autism controversy, 
they want to be able to opt out, regardless of what it means for society at large. This after-effect 
of the myth is much more difficult to address in a place like the United States, with its emphasis 
on individual freedom. Once again, the best starting place may be the physician’s office, where 
parents can be educated on how vaccinations can indirectly help to protect the most vulnerable 
members of the population. If parents can be made to understand that their choices may help to 
protect other children, especially those who are too young to be vaccinated themselves, they may 
be more open to vaccination. This may be even more true if the discussion also includes 
information about the safety of vaccines, the difference between correlation and causation in the 
autism context, and the dangers presented by non-vaccination. Ultimately, by taking the time to 
speak with parents, to let parents give voice to their concerns, and to educate parents on both the 
risks of non-vaccination as well as the benefits of vaccination, physicians may be able to reclaim 
a place of prominence and expertise in the eyes of parents, in spite of the vast amounts of 
information available through the Internet. At the very least, parents may become more willing to 
turn to physicians for information, instead of just relying on Google results. If this were to occur, 
then the harmful consequences of the vaccine-autism myth may finally be mitigated. In addition, 
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should other myths arise in the future, the medical community will be able to use the trust that it 
has built with the public to stop the propagation of those myths. 
Conclusion 
  Regardless of which side one falls on in the vaccine-autism controversy, the underlying 
concern is children’s safety. For those who are skeptical of vaccines, they worry that getting 
children vaccinated may harm them by consigning them to a life of autism and its associated 
developmental and behavioral problems. For those who believe in vaccination, the worry is that 
unprotected children will be vulnerable to a host of potentially deadly diseases. It is this common 
concern over the welfare of children that must be emphasized in efforts to dispel the vaccine-
autism myth. Parents want what is best for their children. The myth propagated by Wakefield has 
convinced many parents that what is best is not vaccination. By taking the time not only to show 
evidence rejecting the vaccine-autism myth, but also to show the risks of not vaccinating, the 
medical community may slowly rebuild faith in vaccines, putting the myth to rest. Such an 
outcome will truly be the best result for children: they will be kept safe from disease while 
resources will be re-devoted to finding the actual causes of autism. 